MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages

Atherosclerosis

Volumn 234, Issue 1, 2014, Pages 54-64

  Zhang, Min ^a   Wu, Jian Feng ^a,b   Chen, Wu Jun ^a   Tang, Shi Lin ^c   Mo, Zhong Cheng ^a   Tang, Yan Yan ^a   Li, Yuan ^a   Wang, Jia Lin ^a   Liu, Xiang Yu ^a   Peng, Juan ^a   Chen, Kong ^a   He, Ping Ping ^a   Lv, Yun Cheng ^a   Ouyang, Xin Ping ^a   Yao, Feng ^a   Tang, Deng Pei ^d   Cayabyab, Francisco S ^d   Zhang, Da Wei ^e   Zheng, Xi Long ^f   Tian, Guo Ping ^b   Tang, Chao Ke ^a   more..

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^c THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

ABCA1; ACAT1; ApoA1; Atherosclerosis; CD36; Cholesterol homeostasis; LPL; MiR 27a b

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CD36 ANTIGEN; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; MICRORNA; MICRORNA 27A; MICRORNA 27B; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; SCAVENGER RECEPTOR BI; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; CHOLESTEROL; MIRN27 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL LEVEL; CELL STRAIN HEPG2; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; MACROPHAGE; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; CELL CULTURE; ESTERIFICATION; HYDROLYSIS; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; CHOLESTEROL; ESTERIFICATION; HUMANS; HYDROLYSIS; MACROPHAGES; MICRORNAS;

EID: 84897944193     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.02.008     Document Type: Article

References (52)

1. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead. Cell 2001, 104:503-516.
2. Pennings M., Meurs I., Ye D., et al. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 2006, 580:5588-5596.
3. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ 2004, 11(Suppl.1):S12-S16.
4. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
5. Chen W.J., Yin K., Zhao G.J., et al. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis 2012, 222:314-323.
6. Jennewein C., von Knethen A., Schmid T., et al. MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. JBiol Chem 2010, 285:11846-11853.
7. Li T., Cao H., Zhuang J., et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chimica Acta; Int J Clin Chem 2011, 412:66-70.
8. Chen W.J., Yin K., Zhao G.J., et al. microRNAs: a new mechanisms for regulation of lipid metabolism. Prog Biochem Biophys 2010, 38:781-790.
9. Vickers K.C., Shoucri B.M., Levin M.G., et al. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 2013, 57:533-542.
10. Kang T., Lu W., Xu W., et al. MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells. JBiol Chem 2013, 288:34394-34402.
11. Vaughan A.M., Tang C., Oram J.F. ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and janus kinase 2 activation. JLipid Res 2009, 50:285-292.
12. Hao X.R., Cao D.L., Hu Y.W., et al. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 2009, 203:417-428.
13. Hu Y.W., Ma X., Li X.X., et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204:e35-e43.
14. Liu X.Y., Lu Q., Ouyang X.P., et al. Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C alpha signaling in THP-1 macrophage-derived foam cells. Atherosclerosis 2013, 226:398-407.
15. Lu Q., Tang S.L., Liu X.Y., et al. Tertiary-butylhydroquinone upregulates expression of ATP-binding cassette transporter A1 via nuclear factor E2-related factor 2/heme oxygenase-1 signaling in THP-1 macrophage-derived foam cells. Circ J Off J Jpn Circ Soc 2013, 77:2399-2408.
16. Rayner K.J., Esau C.C., Hussain F.N., et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478:404-407.
17. Tang S.L., Chen W.J., Yin K., et al. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRalpha through the IGF-I-mediated signaling pathway. Atherosclerosis 2012, 222:344-354.
18. Yvan-Charvet L., Ranalletta M., Wang N., et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. JClin Invest 2007, 117:3900-3908.
19. Zhao G.J., Tang S.L., Lv Y.C., et al. Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression. PloS One 2013, 8:e74782.
20. Zhao G.J., Tang S.L., Lv Y.C., et al. NF-kappaB suppresses the expression of ATP-binding cassette transporter A1/G1 by regulating SREBP-2 and miR-33a in mice. Int J Cardiol 2014, 171(3):e93-e95.
21. Rayner K.J., Sheedy F.J., Esau C.C., et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. JClin Invest 2011, 121:2921-2931.
22. Rayner K.J., Suarez Y., Davalos A., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
23. Yin K., Deng X., Mo Z.C., et al. Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3. JBiol Chem 2011, 286:13834-13845.
24. Tian G.P., Chen W.J., He P.P., et al. MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie 2012, 94:2749-2755.
25. Rigamonti E., Helin L., Lestavel S., et al. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res 2005, 97:682-689.
26. Blom T., Back N., Mutka A.L., et al. FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. Circ Res 2010, 106:720-729.
27. Wang J., Song Y., Zhang Y., et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2012, 22:516-527.
28. Shirasaki T., Honda M., Shimakami T., et al. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. JVirol 2013, 87:5270-5286.
29. Du JK and Huang QY. Research progress of lipoprotein lipase gene, Yi Chuan= Hereditas/Zhongguo yi chuan xue hui bian ji 2007;29:8-16.
30. Olivecrona G., Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 2010, 21:409-415.
31. Karbiener M., Fischer C., Nowitsch S., et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 2009, 390:247-251.
32. Kim S.Y., Kim A.Y., Lee H.W., et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 2010, 392:323-328.
33. Gautam S., Banerjee M. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol Genet Metab 2011, 102:389-398.
34. Chang T.Y., Li B.L., Chang C.C., et al. Acyl-coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab 2009, 297:E1-E9.
35. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
36. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
37. Wang D., Xia M., Yan X., et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res 2012, 111:967-981.
38. Mo W., Zhang J., Li X., et al. Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer. PloS One 2013, 8:e56592.
39. Borel F., Han R., Visser A., et al. Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 2012, 55:821-832.
40. Hoekstra M., van der Sluis R.J., Kuiper J., et al. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. JNutr Biochem 2012, 23:622-628.
41. Kim J., Yoon H., Ramirez C.M., et al. MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol 2012, 235:476-483.
42. Ramirez C.M., Davalos A., Goedeke L., et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011, 31:2707-2714.
43. Sun D., Zhang J., Xie J., et al. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett 2012, 586:1472-1479.
44. Xu J., Hu G., Lu M., et al. MiR-9 reduces human acyl-coenzyme A:cholesterol acyltransferase-1 to decrease THP-1 macrophage-derived foam cell formation. Acta Biochim Biophys Sin 2013, 45(11):953-962.
45. Haas M.J., Reinacher D., Li J.P., et al. Regulation of apoA1 gene expression with acidosis: requirement for a transcriptional repressor. JMol Endocrinol 2001, 27:43-57.
46. Plutzky J. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance. Circ Res 2011, 108:1002-1016.
47. Chen T., Li Z., Tu J., et al. MicroRNA-29a regulates pro-inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL-stimulated dendritic cells. FEBS Lett 2011, 585:657-663.
48. Ouimet M., Marcel Y.L. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012, 32:575-581.
49. Sekiya M., Osuga J., Igarashi M., et al. The role of neutral cholesterol ester hydrolysis in macrophage foam cells. JAtheroscler Thromb 2011, 18:359-364.
50. Kedi X., Ming Y., Yongping W., et al. Free cholesterol overloading induced smooth muscle cells death and activated both ER- and mitochondrial-dependent death pathway. Atherosclerosis 2009, 207:123-130.
51. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. JClin Invest 2002, 110:905-911.
52. Yao P.M., Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. JBiol Chem 2001, 276:42468-42476.